Cochrane Systematic Review: Antibiotics for community-acquired pneumonia in children
Lodha R, Kabra SK, Pandey RM
Lodha R, Kabra SK, Pandey RM
OBJECTIVES: To identify effective antibiotic drug therapies for community-acquired pneumonia (CAP) of varying severity in children by comparing various antibiotics.
OBJECTIVES: To identify effective antibiotic drug therapies for community-acquired pneumonia (CAP) of varying severity in children by comparing various antibiotics.
Cochrane Systematic Review: Antibiotics for treating community acquired pneumonia in people with sickle cell disease
Mart-Carvajal AJ, Conterno LO
Mart-Carvajal AJ, Conterno LO
OBJECTIVES: To determine the efficacy and safety of the antibiotic treatment approaches (monotherapy or combined) for people with sickle cell disease suffering from community-acquired pneumonia.
OBJECTIVES: To determine the efficacy and safety of the antibiotic treatment approaches (monotherapy or combined) for people with sickle cell disease suffering from community-acquired pneumonia.
Cochrane Systematic Review: Antibiotics for community-acquired pneumonia in children
Lodha R, Kabra SK, Pandey RM
Lodha R, Kabra SK, Pandey RM
OBJECTIVES: To identify effective antibiotic drug therapies for community-acquired pneumonia (CAP) of varying severity in children by comparing various antibiotics.
OBJECTIVES: To identify effective antibiotic drug therapies for community-acquired pneumonia (CAP) of varying severity in children by comparing various antibiotics.
Cochrane Systematic Review: Antibiotics for treating community acquired pneumonia in people with sickle cell disease
Mart-Carvajal AJ, Conterno LO
Mart-Carvajal AJ, Conterno LO
OBJECTIVES: To determine the efficacy and safety of the antibiotic treatment approaches (monotherapy or combined) for people with sickle cell disease suffering from community-acquired pneumonia.
OBJECTIVES: To determine the efficacy and safety of the antibiotic treatment approaches (monotherapy or combined) for people with sickle cell disease suffering from community-acquired pneumonia.